NH TherAguix develops and commercializes drug candidates for the treatment of solid tumors.
Business Model:
Revenue: $1.5M
Employees: 11-50
Address: The Atrium - 43 boulevard
City: Villeurbanne
State: auvergne
Zip: 69100
Country: FR
NH TherAguix develops and commercializes drug candidates for the treatment of solid tumors.
Contact Phone:
Contact Email:
Listed Exchange:
Other
Ticker Symbol:
ALNHT
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2019 | Series A | 4 | $14.6M |
Supernova Invest Omnes Capital Bpifrance Arbevel Supernova Invest Omnes Capital Bpifrance Arbevel |
4/2019 | Series A | $14.7M |
Bpifrance Arbevel Supernova Invest Omnes |
4/2019 | Series A | 4 | $14.6M |
Arbevel Bpifrance Omnes Capital Supernova Invest Arbevel Bpifrance Omnes Capital Supernova Invest |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|